Truncation of the cytoplasmic tail of membrane-bound IgE in vivo results in lower serum IgE levels, decreased numbers of IgE-secreting plasma cells and the abrogation of specific secondary immune responses. Here we present mouse strain KN1 that expresses a chimeric e-c1 BCR, consisting of the extracellular domains of the e gene and the transmembrane and cytoplasmic domains of the c1 gene. Thus, differences in the IgE immune response of KN1 mice reflect the influence of the ''c1-mediated signalling'' of mIgE bearing B cells. KN1 mice show an increased serum IgE level, resulting from an elevated number of IgE-secreting cells. Although the primary IgE immune response in KN1 mice is inconspicuous, the secondary response is far more robust. Most strikingly, IgE-antibody secreting cells with ''c1-signalling history'' migrate more efficiently towards the chemokine CXCL12, which guides plasmablasts to plasma cell niches, than IgE-antibody secreting cells with WT ''e-signalling history''. We conclude that IgE plasmablasts have an intrinsic, lower chance to contribute to the long-lived plasma cell pool than IgG1 plasmablasts.Key words: B cells . Chemokines . Immunoglobulins . Knockout mice . Memory cells
Supporting Information available online
IntroductionSerum antibodies, in particular the isotypes other than IgM, bear the individual humoral immunological memory. They are produced by plasma cells, relatively long-lived cells, which integrate the recent immunological history into a longer-lasting, protective shield [1,2]. Unfortunately, in predisposed individuals, they also perpetuate the production of unwanted, harmful antibodies, like IgE in allergy and autoantibodies in autoimmune diseases [3]. The plasma cell, the final cell type in a long B-cell differentiation process, can be identified based on the expression of specific markers. Several markers that are specific for the B-cell lineage are down-regulated upon plasma cell differentiation, including major histocompatibility complex class II, CD19, CD21, CD22 and CD45 [4]. In contrast, the proteoglycan syndecan-1 (syn-1 or CD138) is up-regulated and serves as an identifying surface marker for plasma cells. Although some plasma cells persist in the spleen, most of them return to their ''place of birth'' and home to the bone marrow or inflamed tissues where they persist for up to several months in survival niches as resident, immobile cells [5,6]. Longevity of the plasma cell is influenced by a broad panel of stimuli, including cytokines like IL-5, IL-6, TNF-a, GM-CSF and, also, the chemokine CXCL12 [7,8].It is believed that the contact with stroma cells in the bone marrow provides further adhesion-dependent signals supporting plasma cell longevity [9]. The lifespan of plasma cells is limited by the immigration of newly formed migratory plasmablasts that compete with old plasma cells for space in the survival niches [3]. The migration of plasmablasts to the bone marrow is a critical differentiation step to long-lived plasma cells. Chemokines and their receptors are cruc...